In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on <i>Campylobacter</i>

In Vitro Therapeutic Efficacy of Furazolidone for Antimicrobial Susceptibility Testing on <i>Campylobacter</i>

<b>Background:</b> <i>Campylobacter</i> causes gastroenteritis worldwide with increasing antimicrobial resistance. Furazolidone (FZD) shows potential in resource-poor areas but needs further study. We aimed to assess the in vitro susceptibility of <i>Campylobacter</i...

Full description

Saved in:
Bibliographic Details
Main Authors: Jeel Moya-Salazar, Alfonso Terán-Vásquez, Richard Salazar-Hernandez, Víctor Rojas-Zumaran, Eliane A. Goicochea-Palomino, Marcia M. Moya-Salazar, Hans Contreras-Pulache
Format: Article
Language:English
Published: MDPI AG 2025-06-01
Series:Antibiotics
Subjects:
<i>Campylobacter</i>
antimicrobial resistance
furazolidone
pediatrics
fluoroquinolones
multidrug resistance
Online Access:https://www.mdpi.com/2079-6382/14/7/636
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2079-6382/14/7/636

Similar Items